We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TOVX market cap is 4.9M. The company's latest EPS is USD -6.5946 and P/E is -0.27.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.22M | -6.22M | -5.39M | -8.49M | -7.89M |
| Net Income | -3.3M | -5.49M | -5.17M | -8.32M | -7.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.66M | -10.16M | -14.27M | -21.58M | -21.43M |
| Net Income | -16.08M | -12.56M | -23.19M | -20.03M | -18.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.55M | 55.22M | 48.73M | 42.39M | 40.11M |
| Total Liabilities | 17.66M | 15.52M | 14.61M | 14.74M | 15.47M |
| Total Equity | 41.15M | 36.96M | 31.39M | 25.9M | 24.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.24M | 8.41M | 70.37M | 71.86M | 55.22M |
| Total Liabilities | 5.75M | 3.15M | 4.96M | 17.3M | 15.52M |
| Total Equity | -1.06M | -7.54M | 65.41M | 51.83M | 36.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.46M | -19M | -4.88M | -8.33M | -12.25M |
| Investing | -146k | -202k | N/A | -1,000 | -1,000 |
| Financing | 2.08M | 625k | N/A | 1.77M | 5.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.87M | -12.17M | -12.89M | -19.08M | -19M |
| Investing | N/A | -9k | -14k | -4.4M | -202k |
| Financing | N/A | 3.36M | 74M | -1.93M | 625k |
| Market Cap | 4.9M |
| Price to Earnings Ratio | -0.27 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 2.78M |
| Average Volume (1 week) | 2.05M |
| Average Volume (1 Month) | 624.19k |
| 52 Week Change | -83.83% |
| 52 Week High | 17.1125 |
| 52 Week Low | 1.14 |
| Spread (Intraday) | 0.04 (2.63%) |
| Company Name | Theriva Biologics Inc |
| Address |
9605 medical center drive rockville, maryland 20850 |
| Website | https://www.syntheticbiologics.com |
| Industry | business services (7300) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
